Skip to Content

WATSON 3219 (Aspirin, Butalbital and Caffeine 325 mg / 50 mg / 40 mg)

Pill with imprint WATSON 3219 is Green & Yellow, Capsule-shape and has been identified as Aspirin, Butalbital and Caffeine 325 mg / 50 mg / 40 mg. It is supplied by Watson Pharmaceuticals.

Aspirin/butalbital/caffeine is used in the treatment of migraine; pain; headache and belongs to the drug class analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine 325 mg / 50 mg / 40 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 3219

Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219

Aspirin, Butalbital and Caffeine

Imprint
WATSON 3219
Strength
325 mg / 50 mg / 40 mg
Color
Green & Yellow
Size
29.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
microcrystalline cellulose, corn starch, magnesium silicate, D&C Yellow No. 10, FD&C Green No. 3, gelatin, ferric oxide red

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-3219 Watson Pharmaceuticals, Inc.
68084-0934 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.